Catalogue
Articles
RSS feedX
Search Filters
Format
Subjects
Library Location
Language
Publication Date2013
Dissertation
Details 
Circulation, ISSN 0009-7322, 02/2015, Volume 131, Issue 5, pp. 451 - 458
Background-Many young adults with moderate hyperlipidemia do not meet statin treatment criteria under the new American Heart Association/American College of...
Hyperlipidemias | Risk | Coronary disease | coronary disease | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | risk | PRIMARY PREVENTION | hyperlipidemias | Prospective Studies | Follow-Up Studies | Humans | Hyperlipidemias - drug therapy | Middle Aged | Risk Factors | Coronary Disease - epidemiology | Male | Coronary Disease - diagnosis | Hyperlipidemias - diagnosis | Hyperlipidemias - epidemiology | Time Factors | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Cohort Studies | Hyperlipidemia | Causes of | Adulthood | Research | Health aspects | Coronary heart disease | Risk factors | coronary heart disease risk | hyperlipidemia | younger patients
Hyperlipidemias | Risk | Coronary disease | coronary disease | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | risk | PRIMARY PREVENTION | hyperlipidemias | Prospective Studies | Follow-Up Studies | Humans | Hyperlipidemias - drug therapy | Middle Aged | Risk Factors | Coronary Disease - epidemiology | Male | Coronary Disease - diagnosis | Hyperlipidemias - diagnosis | Hyperlipidemias - epidemiology | Time Factors | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Cohort Studies | Hyperlipidemia | Causes of | Adulthood | Research | Health aspects | Coronary heart disease | Risk factors | coronary heart disease risk | hyperlipidemia | younger patients
Journal Article
Details
Digital rights
Loading RightsNature Medicine, ISSN 1078-8956, 01/2009, Volume 15, Issue 1, pp. 97 - 103
Atherosclerosis is characterized by chronic inflammation of the arterial wall due to chemokine-driven mononuclear cell recruitment. Activated platelets can...
MEDICINE, RESEARCH & EXPERIMENTAL | RECRUITMENT | CELLS | RANTES | BIOCHEMISTRY & MOLECULAR BIOLOGY | MONOCYTE ARREST | GLYCOSAMINOGLYCAN BINDING | DEFICIENT MICE | PLATELET-FACTOR-4 | APOLIPOPROTEIN-E | CELL BIOLOGY | ENDOTHELIUM | CCR5 | CD5 Antigens - genetics | Hyperlipidemias - genetics | Protein Binding - genetics | Atherosclerosis - genetics | Molecular Sequence Data | Atherosclerosis - etiology | Protein Multimerization - genetics | Female | Hyperlipidemias - complications | Platelet Factor 4 - genetics | Amino Acid Sequence | Atherosclerosis - pathology | Hyperlipidemias - metabolism | Mice, Inbred C57BL | Models, Molecular | Chemokines - genetics | Atherosclerosis - metabolism | Mice, Knockout | Aorta - pathology | Animals | Blood Platelets - metabolism | Apolipoproteins E - genetics | Hyperlipidemias - pathology | Chemokines - metabolism | Mice | Prevention | Blood platelets | Atherosclerosis | Physiological aspects | Research | Risk factors | Chemokines | Cardiovascular disease | Lipids | Diet | Rodents | Veins & arteries
MEDICINE, RESEARCH & EXPERIMENTAL | RECRUITMENT | CELLS | RANTES | BIOCHEMISTRY & MOLECULAR BIOLOGY | MONOCYTE ARREST | GLYCOSAMINOGLYCAN BINDING | DEFICIENT MICE | PLATELET-FACTOR-4 | APOLIPOPROTEIN-E | CELL BIOLOGY | ENDOTHELIUM | CCR5 | CD5 Antigens - genetics | Hyperlipidemias - genetics | Protein Binding - genetics | Atherosclerosis - genetics | Molecular Sequence Data | Atherosclerosis - etiology | Protein Multimerization - genetics | Female | Hyperlipidemias - complications | Platelet Factor 4 - genetics | Amino Acid Sequence | Atherosclerosis - pathology | Hyperlipidemias - metabolism | Mice, Inbred C57BL | Models, Molecular | Chemokines - genetics | Atherosclerosis - metabolism | Mice, Knockout | Aorta - pathology | Animals | Blood Platelets - metabolism | Apolipoproteins E - genetics | Hyperlipidemias - pathology | Chemokines - metabolism | Mice | Prevention | Blood platelets | Atherosclerosis | Physiological aspects | Research | Risk factors | Chemokines | Cardiovascular disease | Lipids | Diet | Rodents | Veins & arteries
Journal Article
Details
Digital rights
Loading RightsAnnals of Hematology, ISSN 0939-5555, 06/2010, Volume 89, Issue 6, pp. 569 - 577
Hyperlipidemic myeloma is a rare and poorly understood variant of multiple myeloma. We report the case of a 53-year-old woman with hyperlipidemic myeloma, skin...
Hypercholesterolemia | Hyperviscosity syndrome | Hyperlipidemia | Multiple myeloma | Paraprotein | Hyperlipidemic myeloma | Skin xanthomas | Myeloma | Triglyceride | Cholesterol | MULTIPLE-MYELOMA | PLANE XANTHOMATOSIS | IGA | AUTOIMMUNE HYPERLIPIDEMIA | LOW-DENSITY-LIPOPROTEIN | III HYPERLIPOPROTEINEMIA | HYPERLIPEMIA | PATIENT | HEMATOLOGY | ASSOCIATION | Paraproteins - metabolism | Hyperlipidemias - metabolism | Multiple Myeloma - diagnosis | Multiple Myeloma - complications | Humans | Middle Aged | Xanthomatosis - complications | Multiple Myeloma - metabolism | Hyperlipidemias - diagnosis | Skin Diseases - diagnosis | Xanthomatosis - diagnosis | Multiple Myeloma - etiology | Skin Diseases - complications | Hyperlipidemias - etiology | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Hyperlipidemias - complications | Transplantation, Homologous - adverse effects | Analysis | Anticholesteremic agents | Bone marrow | Triglycerides | Transplantation | Universities and colleges | Immunoglobulin A
Hypercholesterolemia | Hyperviscosity syndrome | Hyperlipidemia | Multiple myeloma | Paraprotein | Hyperlipidemic myeloma | Skin xanthomas | Myeloma | Triglyceride | Cholesterol | MULTIPLE-MYELOMA | PLANE XANTHOMATOSIS | IGA | AUTOIMMUNE HYPERLIPIDEMIA | LOW-DENSITY-LIPOPROTEIN | III HYPERLIPOPROTEINEMIA | HYPERLIPEMIA | PATIENT | HEMATOLOGY | ASSOCIATION | Paraproteins - metabolism | Hyperlipidemias - metabolism | Multiple Myeloma - diagnosis | Multiple Myeloma - complications | Humans | Middle Aged | Xanthomatosis - complications | Multiple Myeloma - metabolism | Hyperlipidemias - diagnosis | Skin Diseases - diagnosis | Xanthomatosis - diagnosis | Multiple Myeloma - etiology | Skin Diseases - complications | Hyperlipidemias - etiology | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Hyperlipidemias - complications | Transplantation, Homologous - adverse effects | Analysis | Anticholesteremic agents | Bone marrow | Triglycerides | Transplantation | Universities and colleges | Immunoglobulin A
Journal Article
Details
Digital rights
Loading RightsAtherosclerosis, ISSN 0021-9150, 2014, Volume 237, Issue 1, pp. 140 - 145
Abstract Objective Controversial findings exist regarding potential influence of statin therapy on diabetic incidence. Aim of this study was to investigate the...
Cardiovascular | Familial combined hyperlipidemia | Heterozygous familial hypercholesterolemia | Diabetes mellitus | Statins | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | EFFICACY | CHOLESTEROL | GUIDELINES | ATORVASTATIN | HEART-DISEASE | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | PRAVASTATIN | CORONARY-ARTERY-DISEASE | ROSUVASTATIN | Blood Pressure | Hyperlipidemias - genetics | Life Style | Hyperlipidemia, Familial Combined - complications | Prospective Studies | Anthropometry | Humans | Middle Aged | Male | Incidence | Adult | Female | Hyperlipidemias - complications | Blood Glucose - chemistry | Hyperlipidemias - drug therapy | Risk Factors | Diabetes Mellitus - drug therapy | Proportional Hazards Models | Diabetes Complications - drug therapy | Hyperlipidemia, Familial Combined - genetics | Treatment Outcome | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Heterozygote | Hyperlipidemia, Familial Combined - drug therapy | Care and treatment | Hypercholesterolemia | Low density lipoproteins | Genetic aspects | Diabetes | Risk factors | Diabetes therapy
Cardiovascular | Familial combined hyperlipidemia | Heterozygous familial hypercholesterolemia | Diabetes mellitus | Statins | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | EFFICACY | CHOLESTEROL | GUIDELINES | ATORVASTATIN | HEART-DISEASE | CARDIOVASCULAR-DISEASE | PERIPHERAL VASCULAR DISEASE | PRAVASTATIN | CORONARY-ARTERY-DISEASE | ROSUVASTATIN | Blood Pressure | Hyperlipidemias - genetics | Life Style | Hyperlipidemia, Familial Combined - complications | Prospective Studies | Anthropometry | Humans | Middle Aged | Male | Incidence | Adult | Female | Hyperlipidemias - complications | Blood Glucose - chemistry | Hyperlipidemias - drug therapy | Risk Factors | Diabetes Mellitus - drug therapy | Proportional Hazards Models | Diabetes Complications - drug therapy | Hyperlipidemia, Familial Combined - genetics | Treatment Outcome | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Heterozygote | Hyperlipidemia, Familial Combined - drug therapy | Care and treatment | Hypercholesterolemia | Low density lipoproteins | Genetic aspects | Diabetes | Risk factors | Diabetes therapy
Journal Article
Details
Digital rights
Loading Rights1993, Disease management/patient counselling series, ISBN 9780919959897, 93
Book
Details
Stroke, ISSN 0039-2499, 01/2014, Volume 45, Issue 1, pp. 315 - 353
Background and Purpose Stroke mortality has been declining since the early 20th century. The reasons for this are not completely understood, although the...
Hyperlipidemias | Hypertension | Stroke | Diabetes mellitus | Risk factors | AHA Scientific Statements | OBSTRUCTIVE SLEEP-APNEA | risk factors | TRANSIENT ISCHEMIC ATTACK | diabetes mellitus | stroke | HEALTH-CARE PROFESSIONALS | LEFT-VENTRICULAR HYPERTROPHY | CLINICAL NEUROLOGY | hyperlipidemias | DENSITY-LIPOPROTEIN CHOLESTEROL | NUTRITION EXAMINATION SURVEY | ACUTE MYOCARDIAL-INFARCTION | BODY-MASS INDEX | BLOOD-PRESSURE CONTROL | PARTICULATE AIR-POLLUTION | PERIPHERAL VASCULAR DISEASE | hypertension | United States - epidemiology | Prevalence | Age Factors | Humans | Middle Aged | Air Pollution - adverse effects | Male | Secondary Prevention | Incidence | Young Adult | Association | Exercise | Atrial Fibrillation - mortality | Aged, 80 and over | Observational Studies as Topic | Adult | Female | Population | Aspirin - therapeutic use | Blood Pressure - physiology | Hypertension - therapy | Stroke - mortality | Diabetes Mellitus - mortality | Platelet Aggregation Inhibitors - therapeutic use | Thrombolytic Therapy - trends | Hyperlipidemias - complications | Stroke - therapy | International Classification of Diseases | Atrial Fibrillation - complications | Thrombolytic Therapy - statistics & numerical data | Clinical Trials as Topic | American Heart Association | Hyperlipidemias - mortality | Heart Diseases - mortality | Smoking - epidemiology | Obesity - epidemiology | Adolescent | Sex Factors | Hypertension - complications | Aged | stroke risks | hyperlipidemia | diabetes
Hyperlipidemias | Hypertension | Stroke | Diabetes mellitus | Risk factors | AHA Scientific Statements | OBSTRUCTIVE SLEEP-APNEA | risk factors | TRANSIENT ISCHEMIC ATTACK | diabetes mellitus | stroke | HEALTH-CARE PROFESSIONALS | LEFT-VENTRICULAR HYPERTROPHY | CLINICAL NEUROLOGY | hyperlipidemias | DENSITY-LIPOPROTEIN CHOLESTEROL | NUTRITION EXAMINATION SURVEY | ACUTE MYOCARDIAL-INFARCTION | BODY-MASS INDEX | BLOOD-PRESSURE CONTROL | PARTICULATE AIR-POLLUTION | PERIPHERAL VASCULAR DISEASE | hypertension | United States - epidemiology | Prevalence | Age Factors | Humans | Middle Aged | Air Pollution - adverse effects | Male | Secondary Prevention | Incidence | Young Adult | Association | Exercise | Atrial Fibrillation - mortality | Aged, 80 and over | Observational Studies as Topic | Adult | Female | Population | Aspirin - therapeutic use | Blood Pressure - physiology | Hypertension - therapy | Stroke - mortality | Diabetes Mellitus - mortality | Platelet Aggregation Inhibitors - therapeutic use | Thrombolytic Therapy - trends | Hyperlipidemias - complications | Stroke - therapy | International Classification of Diseases | Atrial Fibrillation - complications | Thrombolytic Therapy - statistics & numerical data | Clinical Trials as Topic | American Heart Association | Hyperlipidemias - mortality | Heart Diseases - mortality | Smoking - epidemiology | Obesity - epidemiology | Adolescent | Sex Factors | Hypertension - complications | Aged | stroke risks | hyperlipidemia | diabetes
Journal Article
Details
Digital rights
Loading RightsPancreas, ISSN 0885-3177, 2014, Volume 43, Issue 4, pp. 548 - 552
Objective This study aimed to investigate the clinical features and incidence trends of hyperlipidemic acute pancreatitis (HLAP) of multicenter studies in...
Clinical features | Acute pancreatitis | Hyperlipidemia | Hypertriglyceridemia | Incidence | ETIOLOGY | hyperlipidemia | MANAGEMENT | acute pancreatitis | DISEASE | hypertriglyceridemia | GASTROENTEROLOGY & HEPATOLOGY | incidence | clinical features | SEVERITY | Severity of Illness Index | Recurrence | Residence Characteristics | Acute Disease | Hyperlipidemias - blood | Pancreatitis - therapy | Pancreatitis - epidemiology | Humans | Risk Factors | Treatment Outcome | Biomarkers - blood | China - epidemiology | Pancreatitis - mortality | Hyperlipidemias - diagnosis | Pancreatitis - diagnosis | Hyperlipidemias - epidemiology | Hyperlipidemias - mortality | Pancreatitis - blood | Time Factors | Hospitals, General | Retrospective Studies | Hyperlipidemias - therapy
Clinical features | Acute pancreatitis | Hyperlipidemia | Hypertriglyceridemia | Incidence | ETIOLOGY | hyperlipidemia | MANAGEMENT | acute pancreatitis | DISEASE | hypertriglyceridemia | GASTROENTEROLOGY & HEPATOLOGY | incidence | clinical features | SEVERITY | Severity of Illness Index | Recurrence | Residence Characteristics | Acute Disease | Hyperlipidemias - blood | Pancreatitis - therapy | Pancreatitis - epidemiology | Humans | Risk Factors | Treatment Outcome | Biomarkers - blood | China - epidemiology | Pancreatitis - mortality | Hyperlipidemias - diagnosis | Pancreatitis - diagnosis | Hyperlipidemias - epidemiology | Hyperlipidemias - mortality | Pancreatitis - blood | Time Factors | Hospitals, General | Retrospective Studies | Hyperlipidemias - therapy
Journal Article
Details
Digital rights
Loading RightsAgeing Research Reviews, ISSN 1568-1637, 2010, Volume 9, Issue 4, pp. 399 - 417
Abstract A growing body of epidemiological evidence suggested that metabolic syndrome (MetS) and Mets components (impaired glucose tolerance, abdominal or...
Neurology | Internal Medicine | Hypertension | Insulin resistance | Metabolic syndrome | Mild cognitive impairment | Alzheimer's disease | Leptin | VASCULAR RISK-FACTORS | INSULIN-DEGRADING ENZYME | AMYLOID-BETA-PROTEIN | TOTAL CHOLESTEROL LEVEL | CELL BIOLOGY | GERIATRICS & GERONTOLOGY | GLUCAGON-LIKE PEPTIDE-1 | RENIN-ANGIOTENSIN SYSTEM | BODY-MASS INDEX | LONG-TERM POTENTIATION | GROWTH-FACTOR EXPRESSION | MIDLIFE BLOOD-PRESSURE | Life Style | Hyperlipidemias - blood | Humans | Obesity, Abdominal - metabolism | Obesity, Abdominal - physiopathology | tau Proteins - metabolism | Metabolic Syndrome - metabolism | Diabetes Mellitus, Type 2 - metabolism | Diabetes Mellitus, Type 2 - epidemiology | Hyperlipidemias - epidemiology | Obesity, Abdominal - epidemiology | Amyloid beta-Peptides - metabolism | Diabetes Mellitus, Type 2 - therapy | Metabolic Syndrome - physiopathology | Aged, 80 and over | Alzheimer Disease - epidemiology | Hypertension - epidemiology | Hypertension - therapy | Hyperlipidemias - physiopathology | Hyperlipidemias - therapy | Metabolic Syndrome - epidemiology | Biomarkers - metabolism | Effect Modifier, Epidemiologic | Alzheimer Disease - physiopathology | Hyperlipidemias - metabolism | Comorbidity | Risk Factors | Alzheimer Disease - therapy | Aging - psychology | Metabolic Syndrome - therapy | Obesity, Abdominal - therapy | Hypertension - physiopathology | Hypertension - metabolism | Cholesterol, HDL - standards | Animals | Diabetes Mellitus, Type 2 - physiopathology | Aging - physiology | Alzheimer Disease - metabolism | Cholesterol, HDL - blood | Aged | Mice | Population Dynamics
Neurology | Internal Medicine | Hypertension | Insulin resistance | Metabolic syndrome | Mild cognitive impairment | Alzheimer's disease | Leptin | VASCULAR RISK-FACTORS | INSULIN-DEGRADING ENZYME | AMYLOID-BETA-PROTEIN | TOTAL CHOLESTEROL LEVEL | CELL BIOLOGY | GERIATRICS & GERONTOLOGY | GLUCAGON-LIKE PEPTIDE-1 | RENIN-ANGIOTENSIN SYSTEM | BODY-MASS INDEX | LONG-TERM POTENTIATION | GROWTH-FACTOR EXPRESSION | MIDLIFE BLOOD-PRESSURE | Life Style | Hyperlipidemias - blood | Humans | Obesity, Abdominal - metabolism | Obesity, Abdominal - physiopathology | tau Proteins - metabolism | Metabolic Syndrome - metabolism | Diabetes Mellitus, Type 2 - metabolism | Diabetes Mellitus, Type 2 - epidemiology | Hyperlipidemias - epidemiology | Obesity, Abdominal - epidemiology | Amyloid beta-Peptides - metabolism | Diabetes Mellitus, Type 2 - therapy | Metabolic Syndrome - physiopathology | Aged, 80 and over | Alzheimer Disease - epidemiology | Hypertension - epidemiology | Hypertension - therapy | Hyperlipidemias - physiopathology | Hyperlipidemias - therapy | Metabolic Syndrome - epidemiology | Biomarkers - metabolism | Effect Modifier, Epidemiologic | Alzheimer Disease - physiopathology | Hyperlipidemias - metabolism | Comorbidity | Risk Factors | Alzheimer Disease - therapy | Aging - psychology | Metabolic Syndrome - therapy | Obesity, Abdominal - therapy | Hypertension - physiopathology | Hypertension - metabolism | Cholesterol, HDL - standards | Animals | Diabetes Mellitus, Type 2 - physiopathology | Aging - physiology | Alzheimer Disease - metabolism | Cholesterol, HDL - blood | Aged | Mice | Population Dynamics
Journal Article
Details
Digital rights
Loading RightsJournal of Cerebral Blood Flow & Metabolism, ISSN 0271-678X, 2/2014, Volume 34, Issue 2, pp. 284 - 287
Hyperlipidemia is a major cardiovascular risk factor associated with progressive cerebrovascular dysfunction and diminished collateral perfusion in stroke....
hyperlipidemia | fasudil | laser speckle flowmetry | FOCAL CEREBRAL-ISCHEMIA | MOUSE | HYPERCHOLESTEROLEMIA | MODEL | BLOOD-FLOW | NEUROSCIENCES | ApoE knockout | DEPOLARIZATIONS | hydroxyfasudil | ENDOCRINOLOGY & METABOLISM | distal middle cerebral artery occlusion | DYSFUNCTION | HEMATOLOGY | Hyperlipidemias - genetics | Brain Ischemia - genetics | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives | Hyperlipidemias - enzymology | Stroke - physiopathology | Stroke - genetics | rho-Associated Kinases - antagonists & inhibitors | Brain Ischemia - enzymology | rho-Associated Kinases - metabolism | Dietary Fats - pharmacology | Hyperlipidemias - physiopathology | Dietary Fats - adverse effects | Hyperlipidemias - drug therapy | rho-Associated Kinases - genetics | Brain Ischemia - physiopathology | Cerebrovascular Circulation | Stroke - drug therapy | Mice, Knockout | Stroke - enzymology | Animals | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology | Brain Ischemia - drug therapy | Hyperlipidemias - pathology | Mice | Protein Kinase Inhibitors - pharmacology | Hyperlipidemias - chemically induced | Age | Original
hyperlipidemia | fasudil | laser speckle flowmetry | FOCAL CEREBRAL-ISCHEMIA | MOUSE | HYPERCHOLESTEROLEMIA | MODEL | BLOOD-FLOW | NEUROSCIENCES | ApoE knockout | DEPOLARIZATIONS | hydroxyfasudil | ENDOCRINOLOGY & METABOLISM | distal middle cerebral artery occlusion | DYSFUNCTION | HEMATOLOGY | Hyperlipidemias - genetics | Brain Ischemia - genetics | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives | Hyperlipidemias - enzymology | Stroke - physiopathology | Stroke - genetics | rho-Associated Kinases - antagonists & inhibitors | Brain Ischemia - enzymology | rho-Associated Kinases - metabolism | Dietary Fats - pharmacology | Hyperlipidemias - physiopathology | Dietary Fats - adverse effects | Hyperlipidemias - drug therapy | rho-Associated Kinases - genetics | Brain Ischemia - physiopathology | Cerebrovascular Circulation | Stroke - drug therapy | Mice, Knockout | Stroke - enzymology | Animals | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology | Brain Ischemia - drug therapy | Hyperlipidemias - pathology | Mice | Protein Kinase Inhibitors - pharmacology | Hyperlipidemias - chemically induced | Age | Original
Journal Article
Details
Digital rights
Loading Rights1989, ISBN 9780723609155, x, 308 p., [4] p. of plates
Book
Details
Clinical Oral Implants Research, ISSN 0905-7161, 09/2019, Volume 30, Issue S19, pp. 137 - 137
Journal Article
Details
Digital rights
Loading Rights